[Federal Register Volume 82, Number 134 (Friday, July 14, 2017)]
[Notices]
[Page 32587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14835]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Rescheduling Notification of the Public Teleconference of the
President's Commission on Combating Drug Addiction and the Opioid
Crisis (Commission)
AGENCY: Office of National Drug Control Policy (ONDCP).
ACTION: Notice of rescheduling of teleconference.
-----------------------------------------------------------------------
SUMMARY: ONDCP is issuing this notice to advise the public that the
Commission is rescheduling the teleconference of the President's
Commission on Combating Drug Addiction and the Opioid Crisis that was
previously scheduled for Monday, July 17th at 4 p.m. EST. The purpose
of the meeting is to review a draft interim report that will be posted
on ONDCP's Commission Web site listed below before the teleconference.
DATES: The teleconference will be held on Monday, July 31st at 4 p.m.
EST.
ADDRESSES: There will be no physical address. The public may call (800)
260-0718 (Access Code 426289) to listen. Please call five minutes
before the start time. If you are part of an organization, please try
to consolidate use to as few lines as possible.
FOR FURTHER INFORMATION CONTACT: General information concerning the
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the
public who wants to obtain information about the Commission or its
meetings that is not already on ONDCP's Web site or who wants to submit
written comments for the Commission's consideration may contact Michael
Passante, Designated Federal Officer (DFO) via email at
[email protected] or telephone at (202) 395-6709. Please note
that ONDCP may post such written comments publicly on our Web site,
including names and contact information that are submitted.
SUPPLEMENTARY INFORMATION: The Commission was established in accordance
with E.O. 13784 of March 29, 2017, the Commission's charter, and the
provisions of the Federal Advisory Committee Act (FACA), as amended, 5
U.S.C. App. 2, to obtain advice and recommendations for the President
regarding drug issues. The Executive Order, charter, and information on
the Members of the Commission are available on ONDCP's Web site. The
Commission will function solely as an advisory body and will make
recommendations regarding policies and practices for combating drug
addiction with particular focus on the current opioid crisis in the
United States. The Commission's final report is due October 1, 2017
unless there is an extension. Per E.O. 13784, the Commission shall:
a. Identify and describe the existing Federal funding used to
combat drug addiction and the opioid crisis;
b. Assess the availability and accessibility of drug addiction
treatment services and overdose reversal throughout the country and
identify areas that are underserved;
c. Identify and report on best practices for addiction prevention,
including healthcare provider education and evaluation of prescription
practices, collaboration between State and Federal officials, and the
use and effectiveness of State prescription drug monitoring programs;
d. Review the literature evaluating the effectiveness of
educational messages for youth and adults with respect to prescription
and illicit opioids;
e. Identify and evaluate existing Federal programs to prevent and
treat drug addiction for their scope and effectiveness, and make
recommendations for improving these programs; and;
f. Make recommendations to the President for improving the Federal
response to drug addiction and the opioid crisis.
Dated: July 11, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-14835 Filed 7-13-17; 8:45 am]
BILLING CODE 3280-F5-P